Bayer A G Ord (OP:BAYZF)

47.47 +1.72 (+3.76%)

Streaming Delayed Price Updated: 12:03 PM EDT, Apr 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bayer A G Ord

< Previous 1 2 3 4 Next >

Microsoft, Bayer Collaborate To Develop Digital Agricultural Tools, Capabilities ↗

November 17, 2021

Microsoft Corp (NASDAQ: MSFT) and Bayer AG (OTC: BAYRY) (OTC: BAYZF) collaborated on new internet-based products aimed at helping farmers and industries...

Via Benzinga

Regeneron Touts Mid-Stage Win For Higher Dose Of Eylea In Age-related Macular Degeneration ↗

August 24, 2021

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) revealed new Phase 2 proof-of-concept trial data on Eylea (aflibercept) injection in patients with wet age-related...

Via Benzinga

Berkeley Lights, Bayer Ink Discovery Pact For Next-Gen Traits In Agricultural Sector, Berkeley Q2 Earnings Miss Estimates ↗

August 11, 2021

Berkeley Lights Inc (NASDAQ: BLI) reports Q2 sales of $19.3 million, +82% Y/Y, but slightly missing the consensus of $19.64 million. The Company expanded the installed...

Via Benzinga

Topics Earnings

Merck - Bayer's Heart Failure Treatment, Verquvo Scores European Nod ↗

July 21, 2021

The European Commission (EC) has approved Merck & Co Inc's (NYSE: MRK) soluble guanylate cyclase (sGC) stimulator Verquvo (vericiguat). Verquvo...

Via Benzinga

Bayer's Kerendia Scores Long-Awaited Kidney & Heart Disease Nod For Type 2 Diabetes ↗

July 12, 2021

The FDA on Friday approved Bayer AG's (OTC: BAYRY) chronic kidney disease (CKD) drug Kerendia (finerenone), the first and only nonsteroidal mineralocorticoid...

Via Benzinga

Why Did Novocure Shares Plunge Today? ↗

July 01, 2021

Novocure Ltd (NASDAQ: NVCR) has announced final results from its phase 2 pilot HEPANOVA trial evaluating Tumor Treating Fields (TTFields) together with Bayer...

Via Benzinga

Exelixis Shares Drop On Mixed Results For Cabometyx Combo In Early Liver Cancer ↗

June 28, 2021

Exelixis Inc (NASDAQ: EXEL) and Ipsen (OTC: IPSEY) have announced mixed interim results from the COSMIC-312 Phase 3 trial evaluating cabozantinib (...

Via Benzinga

Bayer's Cell, Gene Therapies for Parkinson's Disease Enters Human Trials ↗

June 08, 2021

Bayer AG’s (OTC: BAYRY) Parkinson’s disease stem cell therapy has officially landed in the clinic, while another treatment for the neurodegenerative...

Via Benzinga

Bayer Buys Two Biotech Firms to Beef Up Radiopharmaceuticals ↗

June 03, 2021

Bayer AG (OTC: BAYRY) will acquire two small biotech companies in a deal that adds an experimental prostate cancer medicine to the German drugmaker's pipeline...

Via Benzinga

Bayer Mulls Ending US Retail Sales Of Weedkiller Glyphosate: Reuters ↗

May 27, 2021

A U.S. judge rejected Bayer AG’s (OTC: BAYRY) plan to try and limit the cost of future class action claims that its Roundup weedkiller causes cancer, saying that...

Via Benzinga

Artificial Intelligence Doctor App Ada Health Closes $90M Funding Led By Bayer, Samsung ↗

May 27, 2021

German digital health firm Ada Health has raised a $90 million funding round at an undisclosed valuation bringing total investment in the company up to around $150...

Via Benzinga

Topics Artificial Intelligence

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.